
Sign up to save your podcasts
Or


Vernakalent, CV death in cancer patients, dapagliflozin, and sacubitril/valsartan are the topics Dr. John Mandrola discusses in this week's podcast.
By Medscape4.9
862862 ratings
Vernakalent, CV death in cancer patients, dapagliflozin, and sacubitril/valsartan are the topics Dr. John Mandrola discusses in this week's podcast.

1,873 Listeners

321 Listeners

549 Listeners

697 Listeners

498 Listeners

166 Listeners

14 Listeners

16 Listeners

3,373 Listeners

137 Listeners

1,149 Listeners

62 Listeners

515 Listeners

368 Listeners

62 Listeners

26 Listeners

8 Listeners

260 Listeners

431 Listeners

272 Listeners